Department of General and Oncological Urology, Praski Hospital, Warsaw, Poland.
Department of Urology, Medical University of Gdańsk, Gdańsk, Poland.
Cancer Med. 2024 Aug;13(16):e70092. doi: 10.1002/cam4.70092.
To examine the epidemiology of penile cancer in Poland compared to other European countries.
Incidence and mortality data were acquired from the national cancer registries in Europe and WHO Mortality Database, respectively. The data are presented as age-standardised morbidity and mortality rates, calculated according to the standard population of the world. We utilised Joinpoint analysis to assess the trends in morbidity and mortality and calculated the average rate of increase or decrease (Annual Percentage Change, Average Annual Percentage Change). Additionally, we estimate the proxy survival rates for each country.
Our study is the first to cover the incidence of penile cancer in many European countries and estimates an approximate survival rate for large populations, which is rarely cited in the literature. The 40+ age group presented graphically in the article covered more than 90% of penile cancer cases and deaths. In the countries examined, there was an excess of deaths over incidence in the oldest age groups (75 years or older). Poland had intermediate incidence and mortality rates.
Unlike many European countries, Poland is witnessing an increasing trend of penile cancer mortality. The higher death toll among those aged 75 years or older may suggest a lack of recognition of cancer symptoms and inadequate attention to elderly patients by the healthcare system. There is also evidence of underreporting penile cancer cases. Establishing centralised healthcare systems for rare cancers is a commendable development that should be emulated by other European countries, including Poland.
研究波兰与其他欧洲国家相比，阴茎癌的流行病学情况。
发病率和死亡率数据分别从欧洲国家癌症登记处和世卫组织死亡率数据库获得。数据以按照世界标准人口计算的年龄标准化发病率和死亡率呈现。我们利用 Joinpoint 分析评估发病率和死亡率的趋势，并计算平均增长率或下降率（年变化百分比、平均年变化百分比）。此外，我们估计了每个国家的代理生存率。
我们的研究首次涵盖了许多欧洲国家的阴茎癌发病率，并估计了大人群的近似生存率，这在文献中很少被引用。文章中以图形方式呈现的 40 岁及以上年龄组涵盖了超过 90%的阴茎癌病例和死亡。在所检查的国家中，最年长的年龄组（75 岁或以上）的死亡人数超过了发病率。波兰的发病率和死亡率处于中等水平。
与许多欧洲国家不同，波兰观察到阴茎癌死亡率呈上升趋势。75 岁及以上人群的死亡人数较高可能表明对癌症症状的认识不足，以及医疗保健系统对老年患者的关注不够。也有证据表明阴茎癌病例报告不足。为罕见癌症建立集中的医疗保健系统是一个值得称赞的发展，其他欧洲国家，包括波兰，都应该效仿。
